DK0746327T3 - Forsuret nitrit som antimikrobielt middel - Google Patents

Forsuret nitrit som antimikrobielt middel

Info

Publication number
DK0746327T3
DK0746327T3 DK95908347T DK95908347T DK0746327T3 DK 0746327 T3 DK0746327 T3 DK 0746327T3 DK 95908347 T DK95908347 T DK 95908347T DK 95908347 T DK95908347 T DK 95908347T DK 0746327 T3 DK0746327 T3 DK 0746327T3
Authority
DK
Denmark
Prior art keywords
antimicrobial agent
acidified nitrite
agent
dosage form
applications
Prior art date
Application number
DK95908347T
Other languages
Danish (da)
English (en)
Inventor
Nigel Benjamin
Hamish Dougall
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9403284A external-priority patent/GB9403284D0/en
Priority claimed from GB9404365A external-priority patent/GB9404365D0/en
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Application granted granted Critical
Publication of DK0746327T3 publication Critical patent/DK0746327T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95908347T 1994-02-21 1995-02-17 Forsuret nitrit som antimikrobielt middel DK0746327T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9403284A GB9403284D0 (en) 1994-02-21 1994-02-21 Acidified nitrite as antimicrobial agent
GB9404365A GB9404365D0 (en) 1994-03-07 1994-03-07 Acidified nitrate as antimicrobial agent
PCT/GB1995/000338 WO1995022335A1 (en) 1994-02-21 1995-02-17 Acidified nitrite as an antimicrobial agent

Publications (1)

Publication Number Publication Date
DK0746327T3 true DK0746327T3 (da) 2004-05-10

Family

ID=26304368

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95908347T DK0746327T3 (da) 1994-02-21 1995-02-17 Forsuret nitrit som antimikrobielt middel

Country Status (17)

Country Link
EP (1) EP0746327B1 (de)
JP (1) JP3875262B2 (de)
KR (1) KR100385297B1 (de)
CN (1) CN1145491C (de)
AT (1) ATE264685T1 (de)
AU (1) AU693851B2 (de)
BR (1) BR9507099A (de)
CA (1) CA2183549C (de)
CZ (1) CZ286286B6 (de)
DE (1) DE69532921T2 (de)
DK (1) DK0746327T3 (de)
ES (1) ES2218541T3 (de)
FI (1) FI114852B (de)
NO (1) NO311494B1 (de)
PL (1) PL180769B1 (de)
PT (1) PT746327E (de)
WO (1) WO1995022335A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
SE9700617D0 (sv) * 1997-02-21 1997-02-21 Kjell Alving New composition
WO2000012112A2 (en) 1998-08-28 2000-03-09 The University Of Bath Treatment of lesions with xanthine oxidoreductase
GB9905425D0 (en) * 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
GB0021317D0 (en) 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
GB0022084D0 (en) * 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
GB0119011D0 (en) * 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
WO2003018102A2 (en) 2001-08-29 2003-03-06 Vectura Limited Topical administration device
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
EP1653978B1 (de) 2003-07-09 2020-06-03 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vervendung von nitritsalzen zur behandlung von cardiovaskulären erkrankungen
PT1861130E (pt) * 2005-02-11 2008-12-02 Nolabs Ab Dispositivo e método para o tratamento de dermatomicose, e em particular de onicomicose
US8557300B2 (en) 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
EP1888510A4 (de) 2005-05-27 2013-01-16 Univ North Carolina Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
BR112012003792B1 (pt) 2009-08-21 2020-05-19 Novan Inc composição tópica, e, uso da composição tópica
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
EP3398618B8 (de) * 2013-10-31 2021-01-20 Origin, Inc. Methoden für die bildung eines diskreten materialstroms in einem plasmazustand
AU2015274551A1 (en) * 2014-06-13 2016-12-22 Origin, Inc. Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals
US10967002B2 (en) * 2014-12-05 2021-04-06 Can Technologies, Inc. Animal feed supplement and method
KR102742963B1 (ko) 2017-06-23 2024-12-16 캔 테크놀로지스 인코포레이티드 육류 품질 개선 방법
US20220257642A1 (en) 2019-06-04 2022-08-18 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
AU2020286677B2 (en) 2019-06-04 2025-12-04 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
WO2021214439A1 (en) 2020-04-23 2021-10-28 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
WO2021214440A1 (en) 2020-04-23 2021-10-28 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
GB202101543D0 (en) 2021-02-04 2021-03-24 Thirty Respiratory Ltd Vaping e-liquid composition and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191750A (en) * 1976-03-08 1980-03-04 Milton Hodosh Method for treating canker sores
JPS5985278A (ja) * 1982-11-05 1984-05-17 Agency Of Ind Science & Technol 食品の保存方法及び保存材
JPH0622540B2 (ja) * 1985-12-18 1994-03-30 株式会社祥光化学研究所 消臭抗菌能を有する構造物

Also Published As

Publication number Publication date
AU1669995A (en) 1995-09-04
CA2183549A1 (en) 1995-08-24
NO311494B1 (no) 2001-12-03
BR9507099A (pt) 1997-09-16
PT746327E (pt) 2004-06-30
FI963232A0 (fi) 1996-08-16
KR100385297B1 (ko) 2003-10-10
PL180769B1 (pl) 2001-04-30
ATE264685T1 (de) 2004-05-15
NO963446D0 (no) 1996-08-19
DE69532921T2 (de) 2005-04-14
CN1144484A (zh) 1997-03-05
EP0746327A1 (de) 1996-12-11
ES2218541T3 (es) 2004-11-16
CZ286286B6 (cs) 2000-03-15
EP0746327B1 (de) 2004-04-21
JP3875262B2 (ja) 2007-01-31
CA2183549C (en) 2006-09-12
WO1995022335A1 (en) 1995-08-24
CZ245696A3 (en) 1997-01-15
NO963446L (no) 1996-10-21
AU693851B2 (en) 1998-07-09
CN1145491C (zh) 2004-04-14
FI114852B (fi) 2005-01-14
FI963232L (fi) 1996-09-12
DE69532921D1 (de) 2004-05-27
JPH09508921A (ja) 1997-09-09
PL316033A1 (en) 1996-12-23

Similar Documents

Publication Publication Date Title
DK0746327T3 (da) Forsuret nitrit som antimikrobielt middel
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
GR3024836T3 (en) Fatty acid based compositions for the control of established plant infections
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AU2001271545A1 (en) Promoting whole body health
HU9301550D0 (en) New hydroxamine acid and n-hydroxy-carbamide derivatives and their applications
BR0111718A (pt) Peptìdeos quimicamente modificados, composições e métodos de produção e uso
MXPA02005173A (es) Composicion farmaceutica para el tratamiento de enfermedades asociadas con disminucion de masa osea.
PL344049A1 (en) Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
DK0964687T3 (da) Farmaceutiske sammensætninger med antimikrobiel aktivitet
FI942115A0 (fi) Jodipropargyyliyhdisteiden ja 1,2-bentsisotiatsolin-3-onin synergistisiä yhdistelmiä sienten ja bakteerien kasvun estämisessä vesinesteissä
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
WO1999067238A3 (en) Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
ATE260097T1 (de) Hopfensäuren zur hemmung von staphylococcus aureus
BG105120A (en) Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
AU695907B2 (en) Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
MX9603535A (es) Nitrito acido como un agente antimicrobiano.
AU2768697A (en) Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
GEP20033144B (en) Hygromycin A Derivatives as Antibacterial Agents
MX2024014811A (es) Composiciones de menaquinol pegilado y metodos de tratamiento
WO2023003882A3 (en) Compounds having selective inactivation activity